SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-002303
Filing Date
2023-11-09
Accepted
2023-11-09 16:18:24
Documents
67
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20230930x10q.htm   iXBRL 10-Q 1863517
2 EX-10.1 tmb-20230930xex10d1.htm EX-10.1 33942
3 EX-31.1 tmb-20230930xex31d1.htm EX-31.1 11699
4 EX-31.2 tmb-20230930xex31d2.htm EX-31.2 11293
5 EX-32.1 tmb-20230930xex32d1.htm EX-32.1 6843
6 GRAPHIC tmb-20230930x10q001.jpg GRAPHIC 68881
  Complete submission text file 0001410578-23-002303.txt   6261188

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmb-20230930.xsd EX-101.SCH 41479
8 EX-101.CAL tmb-20230930_cal.xml EX-101.CAL 52113
9 EX-101.DEF tmb-20230930_def.xml EX-101.DEF 192822
10 EX-101.LAB tmb-20230930_lab.xml EX-101.LAB 371093
11 EX-101.PRE tmb-20230930_pre.xml EX-101.PRE 271098
61 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230930x10q_htm.xml XML 853740
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Filer) CIK: 0001828185 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40367 | Film No.: 231392761
SIC: 2834 Pharmaceutical Preparations